Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

Skip to main content
Fig. 5 | Cellular & Molecular Biology Letters

Fig. 5

From: KLF5 enhances CXCL12 transcription in adipose-derived stem cells to promote endothelial progenitor cells neovascularization and accelerate diabetic wound healing

Fig. 5

Expression of KLF5 in wound tissue and the verification of the targeted regulation relationship between KLF5 and CXCL12. A Histological analysis of KLF5 in wound tissue in patients with diabetic ulcers and diabetic mice. × 100, Scale bar = 50 μm; ×200, Scale bar = 100 μm. B Immunofluorescence diagram of KLF5 in the wound tissue of diabetic mice on day 14 post-wounding; dashed line is the boundary between epidermis and dermis; E is the epidermis and D is the dermis. Scale bar = 50 μm. C Targeted modulation was measured by luciferase reporter gene assays. The ratios of Firefly luciferase (FLU) activity to Renilla luciferase (RLU) activity are displayed. D Western blot analysis of KLF5 protein expression in each group of ADSCs. E Western blot quantitative analysis of KLF5 expression level. F ELISA detection of CXCL12 secretion in the culture supernatant of ADSCs. All experiments were performed in triplicate and were repeated three times to confirm the findings (*p < 0.05). Data represent mean ± SD, *p < 0.05, ** p < 0.01, ns, not significant

Back to article page